======= TRAPPC3 ======= == Gene Information == * **Official Symbol**: TRAPPC3 * **Official Name**: trafficking protein particle complex 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27095|27095]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43617|O43617]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TRAPPC3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TRAPPC3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610955|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a component of the trafficking protein particle complex, which tethers transport vesicles to the cis-Golgi membrane. The encoded protein participates in the regulation of transport from the endoplasmic reticulum to the Golgi apparatus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]. * **UniProt Summary**: May play a role in vesicular transport from endoplasmic reticulum to Golgi. |TRAPP| |cis-Golgi network membrane| |TRAPP complex| |intra-Golgi vesicle-mediated transport| |Rab guanyl-nucleotide exchange factor activity| |COPII vesicle coating| |vesicle targeting, rough ER to cis-Golgi| |vesicle coating| |COPII-coated vesicle budding| |vesicle targeting, to, from or within Golgi| |Golgi vesicle budding| |vesicle targeting| |vesicle budding from membrane| |establishment of vesicle localization| |vesicle localization| |endoplasmic reticulum to Golgi vesicle-mediated transport| |vesicle organization| |establishment of organelle localization| |Golgi vesicle transport| |organelle localization| |Golgi membrane| |membrane organization| |Golgi apparatus| |endoplasmic reticulum| |intracellular transport| |protein-containing complex assembly| |establishment of localization in cell| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-2.27| |[[:results:exp143|Phenformin 20μM R03 exp143]]|-2.06| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|-2.05| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.92| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.91| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-1.9| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|-1.89| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|-1.88| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|-1.87| |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|-1.85| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|-1.81| |[[:results:exp16|DABN 2μM R00 exp16]]|-1.76| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|-1.75| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.74| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-1.7| |[[:results:exp401|SNS-032 25μM R07 exp401]]|1.96| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.545| |[[:human genes:r:rabggtb|RABGGTB]]|0.414| |[[:human genes:n:nsmce1|NSMCE1]]|0.413| Global Fraction of Cell Lines Where Essential: 721/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|27/28| |bone|25/26| |breast|31/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|12/13| |fibroblast|1/1| |gastric|15/16| |kidney|20/21| |liver|20/20| |lung|74/75| |lymphocyte|15/16| |ovary|26/26| |pancreas|23/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|23/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|20/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2004 * **Expression level (log2 read counts)**: 5.58 {{:chemogenomics:nalm6 dist.png?nolink |}}